Investigational TMS Treatment for Depression

Last updated: May 10, 2021
Sponsor: White River Junction Veterans Affairs Medical Center
Overall Status: Trial Not Available

Phase

N/A

Condition

Depression

Treatment

N/A

Clinical Study ID

NCT03175887
D17107
  • Ages 21-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study is aimed to help us learn about the effects of Transcranial Magnetic Stimulation at the forehead versus the left side of the head for treatment of Treatment Resistant Depression.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 21-70 years old
  • inadequate response to one current antidepressant medication
  • currently depressed

Exclusion

Exclusion Criteria:

  • psychiatric comorbidities

Study Design

Study Start date:
September 01, 2021
Estimated Completion Date:
September 30, 2022

Study Description

While transcranial magnetic stimulation (TMS) to the left dorsolateral prefrontal cortex (DLPFC) is an FDA approved treatment for depression, a growing and converging database suggests the medial prefrontal cortex (MPFC) may be even more critical to the neurobiology of depression and antidepressant treatment response. This study will compare the efficacy of high frequency transcranial madntic stimulation on these two sections of the brain.

Connect with a study center

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire 03766
    United States

    Site Not Available

  • White River Junction VA Medical Center

    White River Junction, Vermont 05009
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.